课题基金 / 基金详情

CONTROL OF OLIGODENDROCYTE DEVELOPMENT BY OLIG2 AND CHROMATIN REMODELLING COMPLEXES

CONTROL OF OLIGODENDROCYTE DEVELOPMENT BY OLIG2 AND CHROMATIN REMODELLING COMPLEXES
OLIG2 和染色质重塑复合物对少突胶质细胞发育的控制
批准号:
BB/S008934/1
负责人:
William Richardson
金额:
$64.43万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

William Richardson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Amazingly, the thousands of different cell types that make up our body - blood cells, muscle cells, nerve cells, for example - all develop from the same single cell, the fertilized egg. Hence, all cell types contain the same DNA, yet each contains a set of specialized proteins that are unique to that particular cell type, on top of a core set of "housekeeping" proteins found in all cells. The "cell-type-specific" proteins are what give a cell its particular identity - what defines it as a blood cell or nerve cell, for example. Examples are haemoglobin (present or "expressed" only in red blood cells), keratin (only in skin cells), insulin (only in pancreatic cells) and so on. How are these characteristic proteins expressed in only one or a few cell types despite the fact that all cells contain the same DNA - the same collection of genes? If we could understand the mechanisms that keep some genes shut down and others highly expressed, we might learn how to convert one cell type into another - for example, to cure diseases in which a particular type of cell is damaged or destroyed. Examples of such diseases are type-one diabetes, in which the pancreatic cells that make insulin are destroyed by the immune system, or motor neuron disease, in which spinal neurons that control muscle movement die for unknown reasons. If we could manufacture replacement cells from healthy cells in the body, or in a dish, this could be extremely helpful.There are many proteins in cells whose function is purely to activate or repress other protein-coding genes, by binding specific DNA sequences next to those genes. Such DNA-binding proteins are called "transcription factors" because they control whether a given gene is "transcribed" into the instructions for assembling the corresponding protein. For example, the transcription factor OLIG2 is present uniquely in cells in the central nervous system called "oligodendrocytes". These cells make "myelin", spiral wraps of insulating membrane around "axons", the long thin extensions of nerve cells that carry electrical impulses from one part of the brain to another. This greatly increases the speed at which information travels around the brain. Without myelin, we literally would not be able to think quickly, or at all! Moreover, when myelin is damaged, as it is during the demyelinating disease multiple sclerosis, nervous function can be seriously compromised. We therefore want to understand how OLIG2 can activate myelin-forming genes uniquely in oligodendrocytes.DNA in chromosomes ("chromatin") is normally tightly wound into a form that makes its encoded information inaccessible. Transcription factors like OLIG2 cannot by themselves unravel the DNA - they need to interact with many other proteins to form large "chromatin remodelling complexes" that can together release a gene from its tightly folded, "closed" state. These complexes are of several types (e.g. INO80 and ISWI complexes) whose individual functions are poorly understood. We recently found that OLIG2 is associated tightly with both of these complexes and others, raising the question of why different complexes are needed, and what do they individually do?Our hypothesis is that the different chromatin remodelling complexes come into play at different stages of oligodendrocyte development to activate different sets of genes that allow progression along the path from early embryonic stem cell to fully mature, myelin-forming oligodendrocyte. Our project will test this idea by identifying the genes associated with the INO80 and ISWI complexes, determining whether and how OLIG2 directs the INO80 and ISWI complexes to those genes and whether different sets of genes are engaged as oligodendrocytes develop. Our experiments will help to illuminate general mechanisms of transcriptional regulation, applicable to all cell types, as well as helping us understand the detailed workings of the mammalian brain.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Structural and Lipidomic Alterations of Striatal Myelin in 16p11.2 Deletion Mouse Model of Autism Spectrum Disorder.
自闭症谱系障碍 16p11.2 缺失小鼠模型中纹状体髓磷脂的结构和脂质组学改变
DOI: 10.3389/fncel.2021.718720
发表时间: 2021
期刊: Frontiers in cellular neuroscience
影响因子: 5.3
作者: [Ju J, Yang X, Jiang J, Wang D, Zhang Y, Zhao X, Fang X, Liao H, Zheng L, Li S, Hou ST, Liang L, Pan Y, Li H, Li N]
通讯作者: Li N
DOI: 10.1016/j.semcdb.2021.02.004
发表时间: 2021-08
期刊: Seminars in cell & developmental biology
影响因子: 7.3
作者: [Nishiyama A, Shimizu T, Sherafat A, Richardson WD]
通讯作者: Richardson WD
DOI: 10.1155/2020/9465398
发表时间: 2020
期刊: Journal of immunology research
影响因子: 4.1
作者: [Lu Y, Wang Y, Zhang Z, Huang J, Yao M, Huang G, Ge Y, Zhang P, Huang H, Wang Y, Li H, Wang W]
通讯作者: Wang W
DOI: 10.1093/jmcb/mjab076
发表时间: 2022-02-24
期刊: Journal of molecular cell biology
影响因子: 5.5
作者: [Zhang GY, Lv ZM, Ma HX, Chen Y, Yuan Y, Sun PX, Feng YQ, Li YW, Lu WJ, Yang YD, Yang C, Yu XL, Wang C, Liang SL, Zhang ML, Li HL, Li WL]
通讯作者: Li WL
I-Corps: In Vitro Cardiac Platform for Drug Discovery and Cardiotoxicity Screens
  • 批准号:
    2335041
  • 项目类别:
    Standard Grant
  • 资助金额:
    $5.0万
  • 财政年份:
    2023
  • 负责人:
    William Richardson
  • 依托单位:
Histone arginine methylation and the control of neural stem cell proliferation and differentiation.
  • 批准号:
    BB/J006602/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $62.89万
  • 财政年份:
    2012
  • 负责人:
    William Richardson
  • 依托单位:
Stem and progenitor cells of the postnatal CNS
  • 批准号:
    G0800575/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $238.87万
  • 财政年份:
    2009
  • 负责人:
    William Richardson
  • 依托单位:
Chemical Production of Excited State Molecules
  • 批准号:
    8413738
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $7.56万
  • 财政年份:
    1985
  • 负责人:
    William Richardson
  • 依托单位:
海外基金